Can catheter-based renal denervation reduce frequency of hospitalization in patients who have resistant hypertension and heart failure with reduced ejection fraction?

0Citations
Citations of this article
2Readers
Mendeley users who have this article in their library.
Get full text

Abstract

Hypertension is one of the most powerful and modifiable risk factors for the development, progression and even decompensation of heart failure. Uncontrolled hypertension increases to frequency of heart failure hospitalizations by increase sympathetic tone. Catheter-based renal denervation has been shown to reduce blood pressure in the treatment of multidrug-resistant hypertension. We report the improvement in clinical status after renal denervation in a 47-year-old male patient with a history of hypertension, chronic ischemic heart failure, and recurrent hospitalizations for acute hypertensive pulmonary edema despite optimal medical therapy.

References Powered by Scopus

Clinical and hemodynamic correlates of sympathetic nerve activity in normal humans and patients with heart failure: Evidence from direct micronenrographic recordings

239Citations
N/AReaders
Get full text

Hypertension and Heart Failure: Prevention, Targets, and Treatment

135Citations
N/AReaders
Get full text

Renal Denervation: A Review

30Citations
N/AReaders
Get full text

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Cite

CITATION STYLE

APA

Güvendi Sengor, B., Yilmaz, C., Keten, M. F., & Zehir, R. (2024). Can catheter-based renal denervation reduce frequency of hospitalization in patients who have resistant hypertension and heart failure with reduced ejection fraction? Hipertension y Riesgo Vascular, 41(3), 198–200. https://doi.org/10.1016/j.hipert.2024.03.003

Save time finding and organizing research with Mendeley

Sign up for free